Tuesday's After-Hours Movers Led By Akebia, Tetraphase, Pep Boys & TiVo


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Shares of Pep Boys-Manny Moe and Jack (NYSE: PBY), which rose 2.36 percent Tuesday, were down slightly after hours.

The small-cap service and automotive aftermarket company reported earnings of $0.09 per share, in line with the Street’s consensus estimate, on below-consensus revenue of $526.55 million (the Street was expecting sales of $529.58 million).

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

TiVo Inc. (NASDAQ: TIVO) was rising on its earnings report. After gaining 2.82 percent during the day, the stock rose another 1.1 percent after the bell, to $9.20.

TiVo delivered second-quarter earnings of $0.11 per share on revenue of $119.45 million, above the Street’s consensus, which called for EPS of $0.09 on sales of $117.56 million, and considerably surpassing the high end of the management’s guidance for revenue of $97 million.

Akebia Therapeutics Inc (NASDAQ: AKBA) rose more than 60 percent after announcing positive top-line results from a Phase 2 study of Vadadustat “in Dialysis Patients with Anemia Related to Chronic Kidney Disease.”

On the opposite side, Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) lost about 80 percent after failing to meet the primary endpoint of statistical non-inferiority for IGNITE2, compared to levofloxacin.

Vitae Pharmaceuticals Inc (NASDAQ: VTAE) rose more than 34 percent, after making public the positive top-line results it achieved “from its Phase 1 single ascending dose clinical study of VTP-43742 in autoimmune disorders.”

Flexion Therapeutics Inc (NASDAQ: FLXN) plummeted about 43 percent after failing to demonstrate statistical significance for the primary endpoint for FX006.


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: NewsFDAAfter-Hours CenterMovers